Revenue grew 8% year-on-year to EUR 3.4 million, driven by Lifecare, with strong SaaS margins and positive operating cash flow for the seventh consecutive quarter. U.S. RTM launch, share buyback, and NHS contracts marked key milestones, while margin expansion is expected as investments moderate.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.